UnitedHealth Group (NYSE:UNH) Earns Overweight Rating from Analysts at KeyCorp

KeyCorp started coverage on shares of UnitedHealth Group (NYSE:UNH) in a research report released on Friday, Marketbeat reports. The brokerage issued an overweight rating and a $675.00 price objective on the healthcare conglomerate’s stock.

A number of other analysts have also commented on the company. Truist Financial boosted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a buy rating in a report on Wednesday, July 17th. TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the stock a buy rating in a report on Wednesday, July 17th. Morgan Stanley boosted their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an overweight rating in a research report on Wednesday, July 17th. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Finally, Wells Fargo & Company upped their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an overweight rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of Buy and an average price target of $617.37.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $607.55 on Friday. The stock has a 50 day moving average of $584.39 and a two-hundred day moving average of $532.15. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a market capitalization of $561.02 billion, a P/E ratio of 40.29, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the company posted $6.14 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s payout ratio is currently 55.70%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently added to or reduced their stakes in the business. Iams Wealth Management LLC boosted its position in UnitedHealth Group by 9.7% during the third quarter. Iams Wealth Management LLC now owns 2,147 shares of the healthcare conglomerate’s stock valued at $1,255,000 after buying an additional 189 shares during the period. Creative Planning boosted its holdings in shares of UnitedHealth Group by 11.0% during the third quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock worth $123,025,000 after purchasing an additional 21,114 shares during the period. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $27,000. Sivia Capital Partners LLC boosted its holdings in shares of UnitedHealth Group by 5.6% during the third quarter. Sivia Capital Partners LLC now owns 2,705 shares of the healthcare conglomerate’s stock worth $1,582,000 after purchasing an additional 143 shares during the period. Finally, Grove Bank & Trust boosted its holdings in shares of UnitedHealth Group by 2.8% during the third quarter. Grove Bank & Trust now owns 7,129 shares of the healthcare conglomerate’s stock worth $4,168,000 after purchasing an additional 195 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.